| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 6326-06-3 | AH-7614 |
≥98% | | 询价 |
| 2 | 504-84-7 | Erysolin |
≥98% | | 询价 |
| 3 | 329319-07-5 | Licofuranocoumarin |
≥98% | | 询价 |
| 4 | 112636-83-6 | Dicyclanil |
≥98% | | 询价 |
| 5 | 142545-11-7 | Adiaft |
≥98% | | 询价 |
| 6 | 24613-06-7 | Razoxane,(R)- |
≥98% | | 询价 |
| 7 | 139689-19-3 | R(+)-6-Bromo-APB HBr |
≥98% | | 询价 |
| 8 | 186392-65-4 | Ingliforib |
≥98% | | 询价 |
| 9 | 1050480-30-2 | PhiKan-083 |
≥98% | | 询价 |
| 10 | 3575-86-8 | Pyridinium,1,1'-(thiodimethylene)bis(4-formyl-,dichloride,dioxime |
≥98% | | 询价 |
| 11 | 566161-24-8 | BMS-566419 |
≥98% | | 询价 |
| 12 | 24049-18-1 | Alclofenac sodium |
≥98% | | 询价 |
| 13 | 926-28-3 | AI 3-27112 |
≥98% | | 询价 |
| 14 | 215258-13-2 | FR167344 |
≥98% | | 询价 |
| 15 | 480-10-4 | astragalin |
≥98% | | 询价 |
| 16 | 164992-25-0 | AR-C67085 |
≥98% | | 询价 |
| 17 | 852690-88-1 | (+)-Xylariamide A |
≥98% | | 询价 |
| 18 | 2182601-80-3 | Azido-PEG8-CH2CO2-PFP |
≥98% | | 询价 |
| 19 | 99465-44-8 | AFD-21 |
≥98% | | 询价 |
| 20 | 195514-23-9 | AP1867 |
≥98% | | 询价 |
| 21 | 70969-38-9 | 6-Hydroxymyosmine |
≥98% | | 询价 |
| 22 | 60176-59-2 | Ro 5-5453 |
≥98% | | 询价 |
| 23 | 2227548-95-8 | SLC13A5-IN-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 24 | 790663-33-1 | PBD-150 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 25 | 85079-48-7 | Brevetoxin-3 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 26 | 15964-79-1 | Methyl homoveratrate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 27 | 1361200-34-1 | BN201 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 28 | 312928-72-6 | CRTh2 antagonist 3 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 29 | 204992-09-6 | Nemifitide diTFA |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 30 | 356783-10-3 | T-705RTP sodium |
≥98% | | 询价 |
| 31 | 2260542-60-5 | OSMI-2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 32 | 28282-25-9 | β-Elemonic Acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 33 | 2140-79-6 | 2'-O-Methyladenosine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 34 | 1293284-49-7 | Seltorexant HCl |
≥98% | | 询价 |
| 35 | 1009583-83-8 | (R)-BMS-816336 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | 299420-83-0 | UC-514321 |
≥98% | | 询价 |
| 37 | | NIR-H2O2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 38 | 217477-25-3 | Sapienic acid sodium |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 39 | 113170-55-1 | L-Ascorbic acid 2-phosphate magnesium |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 40 | 1644156-80-8 | DHODH-IN-2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 41 | 125969-54-2 | 2-(Dimethylamino)acetaldehyde HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 42 | 1410101-89-1 | (R)-PS210 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 43 | 402939-18-8 | 1-Cyclohexyl-3-dodecyl urea |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 44 | 2170209-51-3 | PD-1/PD-L1-IN 5 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 45 | 2332897-85-3 | Nav1,1 activator 1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 46 | 2093401-85-3 | OTS186935 triHCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 47 | 2230973-67-6 | FGFR4-IN-4 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 48 | 2242855-68-9 | NR1H4 activator 1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 49 | 2253878-44-1 | BCL6-IN-3 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 50 | 2229974-73-4 | XY028-133 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 51 | 2252242-32-1 | RAS GTPase inhibitor 1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 52 | 1000403-03-1 | INT-767 sodium |
≥98% | | 询价 |
| 53 | 2100306-56-5 | Azido-PEG2-t-Boc-hydrazide |
≥98% | | 询价 |
| 54 | 5002-47-1 | Fluphenazine decanoate |
≥98% | | 询价 |
| 55 | 22248-79-9 | Tetrachlorvinphos |
≥98% | | 询价 |
| 56 | 5086-74-8 | Tetramisole hydrochloride |
≥98% | | 询价 |
| 57 | 70114-87-3 | Folic acid,methyl- |
≥98% | | 询价 |
| 58 | 96969-83-4 | BML-266 |
≥98% | | 询价 |
| 59 | 85118-42-9 | Lufuradom |
≥98% | | 询价 |
| 60 | 29050-11-1 | Seclazone |
≥98% | | 询价 |
m.cnreagent.com